Chu Cong-Qiu
Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, Oregon 97239, USA.
Innovent Biologics (USA), Rockville, Maryland 20850, USA.
Rheumatol Immunol Res. 2023 Apr 18;4(1):4-10. doi: 10.2478/rir-2023-0002. eCollection 2023 Mar.
Our understanding of the pathogenesis of large vessel vasculitis (LVV) are mainly achieved by studying the arteries taken from temporal artery biopsy in giant cell arteries (GCA) or surgical or autopsy specimens in Takayasu arteritis (TAK). These artery specimens provide invaluable information about pathological changes in these conditions that GCA and TAK are similar but are distinctly different in immune cell infiltrate and distribution of inflammatory cells in anatomical locations. However, these specimens of established arteritis do not provide information of the arteritis initiation and early events which are impossible to obtain in human artery specimens. Animal models for LVV are needed but not available. Here, several approaches are proposed for experimentation to generate animal models to aid in delineating the interaction of immune reaction with arterial wall components.
我们对大血管血管炎(LVV)发病机制的理解主要是通过研究取自巨细胞动脉炎(GCA)颞动脉活检的动脉,或大动脉炎(TAK)的手术或尸检标本实现的。这些动脉标本提供了关于这些疾病病理变化的宝贵信息,即GCA和TAK相似,但在免疫细胞浸润和炎症细胞在解剖位置的分布上明显不同。然而,这些已确诊动脉炎的标本并未提供动脉炎起始和早期事件的信息,而这些信息在人体动脉标本中是无法获得的。需要LVV的动物模型,但目前尚无可用模型。在此,提出了几种实验方法来生成动物模型,以帮助描绘免疫反应与动脉壁成分之间的相互作用。